CLINICAL_TRIALS
trial_result
· 2023-06-12
Clinical Trial Update: Pembrolizumab in Metastatic Anal Cancer [Phase 2]
Summary
Phase 2 trial of pembrolizumab in metastatic anal cancer completed; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Anal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-06-12